Iberiotoxin-induced block of Ca2+-activated K+ channels induces dihydropyridine sensitivity of ACh release from mammalian motor nerve terminals

J Pharmacol Exp Ther. 2003 May;305(2):646-52. doi: 10.1124/jpet.102.046102. Epub 2003 Jan 24.

Abstract

The role which Ca(2+)-activated K(+) (K(Ca)) channels play in regulating acetylcholine (ACh) release was examined at mouse motor nerve terminals. In particular, the ability of the antagonist iberiotoxin to recruit normally silent L-type Ca(2+) channels to participate in nerve-evoked release was examined using conventional intracellular electrophysiological techniques. Incubation of cut hemidiaphragm preparations with 10 microM nimodipine, a dihydropyridine L-type Ca(2+) channel antagonist, had no significant effect on quantal content of end-plate potentials. Nevertheless, 1 microM S-(-)-1,4-dihydro-2,6-dimethyl-5-nitro-4-(2-[trifluoromethyl]phenyl)-3-pyridine carboxylic acid methyl ester (Bay K 8644) enhanced quantal content to 134.7 +/- 3.5% of control. Iberiotoxin (150 nM) increased quantal content to 177.5 +/- 9.9% of control, whereas iberiotoxin plus nimodipine increased quantal content to only 145.7 +/- 10.4% of control. Coapplication of 1 microM Bay K 8644 with iberiotoxin did not significantly increase quantal content further than did treatment with iberiotoxin alone. The effects of iberiotoxin and nimodipine alone or in combination on the miniature end-plate potential (MEPP) frequency following KCl-induced depolarization were examined using uncut hemidiaphragm preparations. Nimodipine alone had no effect on MEPP frequency from preparations incubated in physiological saline containing 5 to 20 mM KCl. Moreover, iberiotoxin alone or combined with nimodipine also had no effect on MEPP frequency in physiological salines containing 5 to 15 mM KCl. At 20 mM KCl, however, iberiotoxin significantly increased MEPP frequency to 125.6% of iberiotoxin-free values; combined treatment with nimodipine and iberiotoxin prevented this increase in MEPP frequency. Thus, loss of functional K(Ca) channels unmasks normally silent L-type Ca(2+) channels to participate in ACh release from motor nerve terminals, particularly under conditions of intense nerve terminal depolarization.

Publication types

  • Research Support, Non-U.S. Gov't
  • Research Support, U.S. Gov't, P.H.S.

MeSH terms

  • Acetylcholine / metabolism*
  • Animals
  • Calcium Channel Blockers / pharmacology*
  • Calcium Channels, L-Type / drug effects
  • Dihydropyridines / pharmacology*
  • Electrophysiology
  • In Vitro Techniques
  • Male
  • Membrane Potentials / drug effects
  • Mice
  • Mice, Inbred ICR
  • Motor Neurons / drug effects
  • Motor Neurons / metabolism*
  • Muscle, Skeletal / drug effects
  • Muscle, Skeletal / innervation
  • Neuromuscular Junction / drug effects
  • Nimodipine / pharmacology
  • Patch-Clamp Techniques
  • Peptides / pharmacology*
  • Potassium Channel Blockers / pharmacology*
  • Potassium Channels, Calcium-Activated / drug effects*
  • Presynaptic Terminals / drug effects
  • Presynaptic Terminals / metabolism*
  • Synaptic Transmission / drug effects

Substances

  • Calcium Channel Blockers
  • Calcium Channels, L-Type
  • Dihydropyridines
  • Peptides
  • Potassium Channel Blockers
  • Potassium Channels, Calcium-Activated
  • Nimodipine
  • iberiotoxin
  • Acetylcholine